Wednesday, 18 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Latest filing alerts

Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.

4:06 PM ET 8-K
Financial Results Revolution Medicines, Inc. RVMD

Revolution Medicines Financial Results

Revolution Medicines reported financial results for the third quarter of 2026, highlighted by the U.S. commercial launch of RASONQUE (daraxonrasib) for metastatic pancreatic cancer. The product generated $197.6 million in net revenue during its first five weeks on the market, with over 5,000 unique patients treated. The company also received a positive CHMP opinion for the drug in the European Union.

Term
Q3 2026

“The U.S. approval and launch of RASONQUE marked a monumental step forward for eligible patients with pancreatic cancer and a transformational quarter for Revolution Medicines, and the CHMP opinion sets the stage for potential approval in the European Union.”

Mark A. Goldsmith, M.D., Ph.D., chief executive officer and chairman of Revolution Medicines
4:06 PM ET 10-Q
Financial Results Insulet Corp PODD

Insulet Q3 2026 Results: Net Income $141M, Up 61.1% YoY

Insulet Corp reported total revenue of $842.0 million for the quarter ended September 30, 2026, a significant increase from $706.3 million in the prior year period. Net income rose to $141.1 million, or $2.03 per diluted share, driven by strong gross profit margins and the absence of related-party revenue dependencies seen in 2025.

Key figure
Net income $141M · +61.1% YoY
4:06 PM ET 8-K
Stock Plan Amendment Annovis Bio, Inc. ANVS

Annovis Bio Stock Plan Amendment

Annovis Bio stockholders approved an amendment to the 2019 Equity Incentive Plan to increase the number of authorized shares available for issuance. Additionally, stockholders approved a charter amendment to double the company's total authorized common stock from 70 million to 140 million shares.

4:06 PM ET 8-K
Financial Results Coherent Corp. COHR

Coherent Financial Results

Coherent Corp. reported strong Q1 fiscal 2027 results with revenue of $2.37 billion, a 50% increase year-over-year. The company highlighted significant growth driven by AI datacenter demand for optical connectivity and raised its long-term non-GAAP gross margin target to above 45% by the end of calendar 2028.

Term
Q1 2027

“Q1 marked a strong start to fiscal 2027, with pro forma revenue up 56% year over year and non-GAAP EPS up 80%. Our established businesses delivered strong growth, while new growth areas are beginning to ramp. As AI datacenters transition from copper to optical connectivity, Coherent’s broad photonics platform and manufacturing scale position us to help customers meet rising needs for bandwidth and energy efficiency. We expect fiscal 2027 pro forma revenue growth to exceed 60%.”

Jim Anderson, CEO

“Our Q1 results delivered substantial operating leverage and durable gross margin expansion, driven by pricing optimization and cost improvements. This margin strength gives us the confidence to raise our longer-term target. We expect to achieve our first quarter with non-GAAP gross margin above 45% before the end of calendar 2028.”

Sherri Luther, CFO
4:06 PM ET 8-K
Dividend Runway Growth Finance Corp. RWAY

Runway Growth Finance Dividend

Runway Growth Finance Corp. declared a regular quarterly cash dividend of $0.33 per share for the fourth quarter of 2026. The dividend is payable on December 3, 2026, to stockholders of record as of November 17, 2026.

Term
Q4 2026
4:06 PM ET 8-K
Financial Results Cytokinetics Inc CYTK

Cytokinetics Financial Results

Cytokinetics reported Q3 2026 financial results, highlighted by $44.5 million in net product revenue from MYQORZO (aficamten). The company ended the quarter with approximately $1.6 billion in cash and plans to submit a supplemental NDA for aficamten in non-obstructive HCM in Q4 2026.

Term
Q3 2026

“Our third quarter results demonstrate continued strong execution as Cytokinetics enters its next phase of growth as a global specialty cardiology biopharmaceutical company.”

Robert I. Blum, Cytokinetics’ President and Chief Executive Officer

“In the U.S., the launch of MYQORZO continued to build solid momentum and increased velocity with growing adoption across a broadening base of prescribers.”

Robert I. Blum, Cytokinetics’ President and Chief Executive Officer
4:06 PM ET 8-K
Shareholder Meeting Fermi Inc. FRMI

Fermi Shareholder Meeting

Fermi Inc. reported results from its 2026 Annual Meeting where shareholders ratified Ernst & Young LLP as auditors but failed to elect two Class I directors, Jeffrey S. Stein and Rick Perry, as they did not receive a majority of outstanding shares. The company alleges that certain investors, including TMNN Manager LLC and the MN Trust, breached a Director Nomination Agreement by voting against Governor Perry, and it reserves the right to seek legal remedies to give effect to the required votes.

4:06 PM ET Form 4
Insider Selling LuxExperience B.V. LUXE

LuxExperience B.V CEO Michael Kliger Sells $183K of Stock

Michael Kliger, CEO, sold 18,237 shares of LuxExperience B.V. at $10.00 to $10.01 a share (average $10.01) in 2 transactions, worth $183K in total between Nov 2, 2026 and Nov 3, 2026. Shares held after the trade: 0 (-100.0%).

Value
$183K
Shares
18,237
Average price
$10.01
Role
CEO
Holding change
-100.0%
Trade date
Nov 2, 2026 to Nov 3, 2026
4:06 PM ET Form 4
Insider Selling DoorDash, Inc. DASH

DoorDash Director Stanley Tang Sells $4.36M of Stock

Stanley Tang, Director, sold 23,125 shares of DoorDash, Inc. at $178.35 to $190.81 a share (average $188.71) in 11 transactions, worth $4.36M in total on Nov 2, 2026. Shares held after the trade: 10,361 (-1.9%).

Value
$4.36M
Shares
23,125
Average price
$188.71
Role
Director
Holding change
-1.9%
Trade date
Nov 2, 2026
4:06 PM ET Form 4
Insider Selling DoorDash, Inc. DASH

DoorDash Director Andy Fang Sells $906K of Stock

Andy Fang, Director, sold 5,000 shares of DoorDash, Inc. at $181.17 a share, worth $906K in total on Nov 2, 2026. Shares held after the trade: 0 (-100.0%).

Value
$906K
Shares
5,000
Price
$181.17
Role
Director
Holding change
-100.0%
Trade date
Nov 2, 2026
4:06 PM ET 8-K
Financial Results Clipper Realty Inc. CLPR

Clipper Realty Financial Results

Clipper Realty Inc. reported record quarterly revenues of $40.5 million for Q3 2026, driven by strong residential leasing demand and high occupancy. The company reported a net loss of $5.9 million, partly impacted by the ongoing resolution of lender issues at its 250 Livingston Street office property following a major lease termination in 2025.

“For the quarter, the main highlights are continued strong residential leasing and significant progress made towards resolving lender issues at our 250 Livingston Street office property. The residential properties continued to have high occupancy and strong renter demand. New free market leases exceeded previous rents by 9% and renewals by over 5% and our major residential properties are leased at very high levels. Furthermore, our new Prospect House property at 953 Dean Street in Brooklyn, NY is fully operational after going in service last year.”

David Bistricer, Co-Chairman and Chief Executive Officer
4:06 PM ET 8-K
Financial Results PureCycle Technologies, Inc. PCT

PureCycle Technologies Financial Results

PureCycle Technologies reported Q3 2026 revenue of $2.3 million, with production at its Ironton facility reaching 5.2 million pounds of resin. The company also announced the appointment of Fernando Musa as Executive Chairman to support commercial activities and strategic goals through 2027.

Term
Q3 2026
4:05 PM ET 10-K
Financial Results Qualcomm Inc QCOM

Qualcomm FY 2026 Results: Net Income $13.6B, Up 145.9% YoY

Qualcomm highlights significant risks related to its internal manufacturing facilities for RFFE modules and RF filters, noting that a higher portion of fixed costs compared to a fabless model could lead to lower gross profits during demand downturns. The company also emphasizes vulnerabilities to environmental regulations, climate change impacts, geopolitical conflicts, and increasingly sophisticated cybersecurity threats that could disrupt production or compromise intellectual property.

Key figure
Net income $13.6B · +145.9% YoY
4:05 PM ET 8-K
Financial Results Sinclair, Inc. SBGI

Sinclair Financial Results

Sinclair reported record Q3 2026 results driven by $136 million in political advertising revenue, a 55% increase over the 2022 mid-term cycle. The company raised its full-year 2026 Adjusted EBITDA guidance to $825-$835 million and announced it has decided not to pursue a standalone spin-off of its Ventures portfolio at this time.

Term
Q3 2026

“Sinclair delivered strong third quarter results, with record mid-term political advertising revenue in both third and fourth quarters, and disciplined execution across the business. Political advertising revenue is expected to exceed our prior record year of 2024 as battleground races and the overall political environment helped drive record demand across our footprint. In addition, we have reached new network affiliation agreements with both ABC and CBS in recent weeks. Lastly, we are increasing our full year 2026 Adjusted EBITDA guidance to a range of $825 million to $835 million, which we note is higher than our 2024 Adjusted EBITDA of $816 million excluding the Diamond-related management fees received in that year.”

Chris Ripley, President and CEO
4:05 PM ET 10-Q
Financial Results Arcutis Biotherapeutics, Inc. ARQT

Arcutis Biotherapeutics Q3 2026 Results: Net Income $8.8M, Up 18.8% YoY

Arcutis Biotherapeutics reported a significant turnaround for the nine months ended September 30, 2026, achieving a net income of $12.5 million compared to a net loss of $33.5 million in the prior year period. This growth was driven by a 55% increase in net product revenue to $379.2 million, though operating expenses also rose to $362.4 million due to higher selling, general, and administrative costs.

Key figure
Net income $8.8M · +18.8% YoY
4:05 PM ET 10-Q
Financial Results Fatpipe Inc FATN

Fatpipe Q2 2026 Results: Turns Profitable, Net Income $1.2M

FatPipe Inc. reported revenues of $9.87 million for the six months ended September 30, 2026, a 25% increase compared to the prior year. Net income for the same period rose significantly to $2.43 million, up from $0.70 million, despite a net decrease in cash driven by increased contracts receivable.

Key figure
Net income $1.2M
4:05 PM ET Form 4
Insider Selling Generate Biomedicines, Inc. GENB

Generate Biomedicines Director Frances Arnold Sells $185K of Stock

Frances Arnold, Director, sold 11,409 shares of Generate Biomedicines, Inc. at $16.19 a share, worth $185K in total on Oct 29, 2026. Shares held after the trade: 220,063 (-4.9%).

Value
$185K
Shares
11,409
Price
$16.19
Role
Director
Holding change
-4.9%
Trade date
Oct 29, 2026
4:05 PM ET Form 4
Insider Selling Stoke Therapeutics, Inc. STOK

Stoke Therapeutics CMO Barry Ticho Sells $185K of Stock

Barry Ticho, CMO, sold 6,995 shares of Stoke Therapeutics, Inc. at $26.38 a share, worth $185K in total on Nov 2, 2026. Shares held after the trade: 12,064 (-36.7%).

Value
$185K
Shares
6,995
Price
$26.38
Role
CMO
Holding change
-36.7%
Trade date
Nov 2, 2026
4:05 PM ET 10-Q
Financial Results Biocryst Pharmaceuticals Inc BCRX

Biocryst Pharmaceuticals Q3 2026 Results: Net Income $37.9M, Up 193.9% YoY

BioCryst Pharmaceuticals reported 257,299,269 shares of common stock outstanding as of October 30, 2026. The filing highlights the commercialization of ORLADEYO, the strategic merger with Astria, and a shift toward prioritizing external innovation and clinical development of product candidates like navenibart.

Key figure
Net income $37.9M · +193.9% YoY
4:05 PM ET 8-K
Dividend Hewlett Packard Enterprise Co HPE

Hewlett Packard Enterprise Dividend

Hewlett Packard Enterprise's Board of Directors declared a cash dividend of $0.953125 per share on its 7.625% Series C Mandatory Convertible Preferred Stock. The dividend is payable on December 1, 2026, to shareholders of record as of November 15, 2026.

4:05 PM ET Form 4
Insider Selling Regeneron Pharmaceuticals, Inc. REGN

Regeneron Pharmaceuticals EVP General Counsel and Secret Joseph J. Larosa Sells $4.31M of Stock

Joseph J. Larosa, EVP General Counsel and Secret, sold 4,466 shares of Regeneron Pharmaceuticals, Inc. at $965.41 to $966.11 a share (average $965.49) in 2 transactions, worth $4.31M in total on Nov 2, 2026. Shares held after the trade: 38,906 (-1.3%).

Value
$4.31M
Shares
4,466
Average price
$965.49
Role
EVP General Counsel and Secret
Holding change
-1.3%
Trade date
Nov 2, 2026
4:05 PM ET 8-K
Financial Results Pattern Group Inc. PTRN

Pattern Group Financial Results

Pattern Group Inc. reported record third-quarter 2026 revenue of $886 million, a 38% increase year-over-year, driven by strong net revenue retention of 127%. The company achieved net income of $32 million and raised its full-year 2026 revenue guidance to a range of $3.50 billion to $3.52 billion.

Term
Q3 2026

“We delivered another record quarter, with revenue of $886 million, up 38% year over year with net revenue retention of 127%. We’re helping existing brand partners grow while more brands choose Pattern to expand their businesses across marketplaces and geographies. This strong momentum underpins our increased full-year outlook.”

Dave Wright, Co-Founder and CEO

“Our record top line performance translated to strong bottom line delivery and meaningful free cash flow generation. On a trailing twelve month basis, the business generated $106 million of free cash flow, enabling us to invest for growth and return value to shareholders. We are raising our full year outlook, underscoring the power of Pattern’s model and our commitment to driving durable growth and long-term shareholder value.”

Jason Beesley, Chief Financial Officer
4:05 PM ET 8-K
Financial Results Accuray Inc ARAY

Accuray Financial Results

Accuray reported fiscal 2027 first quarter results with total net revenue of $86.5 million, an 8% decrease year-over-year, primarily due to lower product revenue. The company recorded a $35.4 million non-cash goodwill impairment charge but noted that transformation initiatives generated $13 million in cost and margin improvements.

“As I said on our last call, fiscal 2026 was a year of transformation, and fiscal 2027 is about execution. During the first quarter, we made progress across several areas. Service margins improved, operating expenses remained well controlled, we strengthened our financial position, and we advanced our innovation roadmap through strategic partnerships with RaySearch and Samsung NeuroLogica.”

Steve La Neve, President and Chief Executive Officer

“At the same time, we see a clear opportunity to improve product and order performance. The customer engagement we saw at ASTRO, the growing clinical evidence supporting precision radiation therapy, and the opportunities created by our innovation strategy reinforce our confidence in the direction we are taking.”

Steve La Neve, President and Chief Executive Officer
4:05 PM ET 8-K
Financial Results Sezzle Inc. SEZL

Sezzle Financial Results

Sezzle Inc. reported record third quarter 2026 results, with total revenue growing 42.6% YoY to $166.5 million and net income increasing 79.3% to $47.8 million. Driven by strong subscriber growth and transaction frequency, the company raised its full-year 2026 guidance and introduced a preliminary 2027 outlook.

Term
Q3 2026

“We enter the holiday season with Subscribers approaching one million and transaction frequency reaching a Company high. SezzleCash is showing encouraging results, bringing new Subscribers onto the platform, many of whom subsequently shop with Anywhere at checkout.”

Charlie Youakim, Sezzle Executive Chairman and CEO
4:04 PM ET 8-K
Financial Results Safety Insurance Group Inc SAFT

Safety Insurance Group Financial Results

Safety Insurance Group reported Q3 2026 net income of $30.0 million, or $2.05 per diluted share, driven by improved underwriting results and record net investment income. The company also declared a quarterly dividend of $0.92 per share and noted that shareholders have approved the pending $1.54 billion acquisition by Mapfre S.A.

Term
Q3 2026

“For the quarter ended September 30, 2026, our combined ratio improved to 96.3% compared to 98.9% in the same period in the prior year. The combined ratio of 96.3% reflects the impact of previous written premium growth earning into top-line revenue, as well as a decrease in losses and loss adjustment expenses incurred, driven by improved loss frequency in our private passenger automobile line. Net income for the quarter ended September 30, 2026 was $30.0 million, or $2.05 per diluted share, compared to net income of $28.3 million, or $1.91 per diluted share, for the comparable 2025 period. The increase in net income reflects the impact of improved underwriting results and the largest quarterly net investment income results in our Company’s history.”

George M. Murphy, Chairman of the Board of Directors, President and Chief Executive Officer
4:04 PM ET 8-K
Financial Results Qualcomm Inc QCOM

Qualcomm Financial Results

Qualcomm reported fiscal fourth quarter and full-year 2026 results, highlighted by record QCT Automotive revenues of $2 billion in the quarter. The company also announced the renewal of long-term licensing agreements with Apple, Huawei, and Transsion, and a new AI data center collaboration with Amazon.

Term
FY2026

“We are pleased to deliver fourth quarter non-GAAP revenues at the high end of our guidance, along with 36% year-over-year growth in combined QCT Automotive and IoT revenues.”

Cristiano Amon, President and CEO of Qualcomm Incorporated

“Fiscal 2027 marks the start of our non-handset revenue inflection, including the ramp of our Data Center business. Non-handset revenues are projected to grow by more than 60% year-over-year, and we are reiterating our fiscal 2027 Data Center revenue target of $5B.”

Cristiano Amon, President and CEO of Qualcomm Incorporated
4:04 PM ET 8-K
Financial Results Upland Software, Inc. UPLD

Upland Software Financial Results

Upland Software reported Q3 2026 revenue of $47.5 million, exceeding the midpoint of its guidance despite a 6% year-over-year decline. The company outlined a three-phase strategic plan (Simplify, Stabilize, Grow) targeting a 35% Adjusted EBITDA margin by the first half of 2028 through AI-driven operational improvements and debt reduction.

Term
Q3 2026

“Our roadmap for this next chapter has three phases: Simplify and Delever, through early 2027; Stabilize and Expand, in 2027; and Grow, in 2028 and beyond, driven by new AI use cases.”

Sean Nathaniel, President and Chief Executive Officer

“In the third quarter, we delivered revenue above the midpoint of our guidance, improved our adjusted EBITDA margin sequentially and continued to pay down debt.”

Sean Nathaniel, President and Chief Executive Officer
4:04 PM ET 8-K
Financial Results PTC Inc. PTC

PTC Financial Results

PTC Inc. reported its fourth quarter and full fiscal year 2026 results, showing a 25% year-over-year revenue decline in Q4 to $673 million, primarily impacted by divestitures. The company also noted it has entered into a definitive agreement to be acquired by Schneider Electric and has consequently suspended its earnings calls and future guidance.

4:04 PM ET 10-Q
Financial Results HMH Holding Inc HMH

HMH Holding Q3 2026 Results: Net Income $4.98M, Down 69.2% YoY

HMH Holding Inc. reported total revenue of $171.1 million for the third quarter of 2026, a decrease from $217.2 million in the same period of 2025, primarily driven by a significant decline in product revenue. For the nine months ended September 30, 2026, total revenue was $513.2 million compared to $619.1 million in the prior year, reflecting broader volatility in the oil and natural gas industry.

Key figure
Net income $4.98M · -69.2% YoY
4:04 PM ET 8-K
Financial Results Legalzoom.Com, Inc. LZ

Legalzoom.Com Financial Results

LegalZoom reported Q3 2026 revenue of $195.1 million, up 3% year-over-year, driven by 11% growth in subscription revenue. The company narrowed its full-year revenue guidance to $797-$803 million and updated its Adjusted EBITDA outlook to $180-$185 million, citing a challenging customer acquisition environment.

Term
Q3 2026

“Revenue from human-in-the-loop subscription services grew 17% year-over-year and now represents 49% of total revenue. These results give us confidence to accelerate our investment in bringing expert support into the customer relationship from the first purchase, pairing AI with accountable expertise to make our services more useful.”

Jeff Stibel, Chairman and Chief Executive Officer

“Subscription growth continues to offset customer acquisition pressure, supporting an unchanged $800 million midpoint for our full-year revenue outlook. Our updated Adjusted EBITDA outlook reflects the cost of that environment and our continued investment in channel diversification and the sales and service capabilities behind our higher-value offerings.”

Noel Watson, Chief Operating Officer and Chief Financial Officer

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.